Dr. Robert Prigmore has held several senior posts culminating in his appointment as Executive Engineer for the UK division of Calsonic Kansei, a major Japanese group.
He was Technical Director with Gibb Law International (now Jacobs Babtie) and in 1996 became the founder of the Hendre Holdings Group of companies, of which he is now the Chairman. Robert has successfully filed three patents all of which are being commercially exploited.
Robert holds an Honours Degree in Chemistry and a PhD in Chemical Engineering and is a Chartered Chemist and Scientist and a Member of the Royal Society of Chemistry. He is responsible for developing the patents, all the licensing and the business model of Egnedol.